<DOC>
	<DOCNO>NCT01133223</DOCNO>
	<brief_summary>Stroke prognosis intimately related reperfusion . Reperfusion acute set achieve different strategy - vary intravenous rtPA mechanical thrombectomy . Recently , interventional approach gain attention play increase role stroke care . However , solid scientifical data available date . The investigator want conduct pilot trial test use Penumbra™ System improve clinical outcome specific stroke setting .</brief_summary>
	<brief_title>Safety Efficacy Penumbra™ System Acute Middle Cerebral Artery ( MCA ) Stroke</brief_title>
	<detailed_description />
	<mesh_term>Stroke</mesh_term>
	<mesh_term>Plasminogen</mesh_term>
	<mesh_term>Tissue Plasminogen Activator</mesh_term>
	<criteria>Patient enrol acute ischemic stroke protocol Up 3,5h symptom onset Clinical finding compatible middle cerebral artery syndrome Angiotomographic evidence proximal middle cerebral artery occlusion NIHSS &lt; 10 Overt contraindication thrombolysis angiopgraphy Disagreement inform consent term refusal participate</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2015</verification_date>
	<keyword>Stroke , mecanical thrombectomy</keyword>
</DOC>